CAS: 156586-90-2 - Cedelizumab
Formula:Unspecified
- Synonyms:
- Cedelizumab
- Immunoglobulin G4, anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementary determining region-grafted γ4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementary determining region-grafted κ-chain, dimer
- Immunoglobulin G 4, (human-mouse monoclonal OKTcdr4a complementary determining region-grafted γ-chain anti-human CD 4 antigen), disulfide with human-mouse monoclonal OKTcdr4a complementary determining region-grafted κ-chain, dimer
- RWJ 49004
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Cedelizumab REF: TM-T82756CAS: 156586-90-2 | - - - | To inquire | Thu 24 Oct 24 | |
Cedelizumab REF: 3D-CLA1073CAS: 156586-90-2 | - - - | To inquire | Tue 05 Nov 24 |
Cedelizumab
CAS:156586-90-2
Cedelizumab (RWJ 49004), an IgG4 monoclonal antibody, selectively targets CD4 and exhibits immunosuppressant properties [1].
Color and Shape:
Solid
Ref: TM-T82756
1mg | To inquire | ||
5mg | To inquire |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1073
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024